Allegiant Travel Co
$3.09B- Market cap
- $2.08B
- Debt
- +$1.82B
- Cash
- −$805.66M
Capital structure 53% equity / 47% debt · EV / Revenue 1.19x · EV / EBITDA 13.08x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: ALGT stock price vs BMRN: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at BMRN's multiple
Needs BMRN P/S.
Implied fair value · at ALGT's multiple
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: ALGT FY 2025 (ended Dec 31, 2025) · BMRN FY 2025 (ended Dec 31, 2025).
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
Market cap plus debt, less cash.
Capital structure 53% equity / 47% debt · EV / Revenue 1.19x · EV / EBITDA 13.08x
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Allegiant Travel Co · implied price per share
Bear
-$52.81
Base
-$52.25
Bull
-$51.53
BIOMARIN PHARMACEUTICAL INC · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
1.73x
0.08x
Net debt / EBITDA
Leverage against operating earnings
4.28x
-1.43x
Cash and equivalents
Liquid reserves on the balance sheet
$805.66M
$1.31B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
JETBLUE AIRWAYS CORP
ALGT vs JBLU
ALASKA AIR GROUP, INC.
ALGT vs ALK
SOUTHWEST AIRLINES CO
ALGT vs LUV
American Airlines Group Inc.
ALGT vs AAL
VERTEX PHARMACEUTICALS INC / MA
ALGT vs VRTX
ALNYLAM PHARMACEUTICALS, INC.
ALGT vs ALNY
Sarepta Therapeutics, Inc.
ALGT vs SRPT
REGENXBIO Inc.
ALGT vs RGNX
IONIS PHARMACEUTICALS INC
ALGT vs IONS
PTC THERAPEUTICS, INC.
ALGT vs PTCT
$1.82B
$505.32M
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.